Drug · DIN 02294435
PHL-RISPERIDONE ODT
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 13, 2017.
- Drug Identification Number (DIN)
- 02294435
- Company (DIN owner)
- Pharmel Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 28, 2008: NOC 9449Supplement to an Abbreviated New Drug Submission (SANDS) · New dosage form - orally disintegrating tablet
Other DINs named PHL-RISPERIDONE ODT
- DIN 02294443 · Cancelled Pre Market
- DIN 02294451 · Cancelled Pre Market